CareDx Reports Third Quarter 2024 Results and Raises Revenue Guidance
CareDx, Inc. (CDNA)
Last caredx, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.caredxinc.com
Company Research
Source: Business Wire
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – today announced financial results for the third quarter ended September 30, 2024.Third Quarter 2024 Financial HighlightsTotal revenue of $82.9 million increased 23% year-over-yearTesting Services volume of 44,600 tests increased 16% year-over-yearGAAP net loss of $7.4 million, non-GAAP net income of $8.0 million, and positive adjusted EBITDA of $6.9 million, a significant improvement from the third quarter 2023Cash flow from operations of $12.5 million. Cash, cash equivalents, and marketable securities of $241 million, with no debtRaised annual revenue guidance to $327 to $331 million and adjusted EBITDA to a gain of $18 to $22 millionBusiness HighlightsCMS reaffirmed longstanding Medicare coverage for AlloSure® and AlloMap® TestingSurveillance testing mix in kidney began to increase in the second half of September and continued through OctoberHired industry veterans Keith Kennedy, Chief Operating Officer; Jessica Me
Show less
Read more
Impact Snapshot
Event Time:
CDNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CDNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CDNA alerts
High impacting CareDx, Inc. news events
Weekly update
A roundup of the hottest topics
CDNA
News
- https://seekingalpha.com/article/4746869-caredx-cdna-stock-too-risky-for-me [Seeking Alpha]Seeking Alpha
- CareDx to Participate in the 43rd Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- CareDx to Participate in the 43rd Annual J.P. Morgan Healthcare ConferenceBusiness Wire
- TCBP Partners with CareDx to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell Therapy [Yahoo! Finance]Yahoo! Finance
- CareDx Partners with TC BioPharm to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell Therapy [Yahoo! Finance]Yahoo! Finance
CDNA
Earnings
- 11/4/24 - Beat
CDNA
Sec Filings
- 12/6/24 - Form 4
- 12/4/24 - Form 144
- 12/3/24 - Form 4
- CDNA's page on the SEC website